BROOKE SISK: Open Payments
NPI 1649891995 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 25 payments from 9 companies in 2025. Trend: 2023 $617 · 2024 $327 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $220 |
| Lilly USA, LLC | 7 | $139 |
| PFIZER INC. | 2 | $33 |
| Novo Nordisk Inc | 2 | $30 |
| ALK-Abello, Inc | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| ABBVIE INC. | 1 | $14 |
Products named: AIRSUPRA, MOUNJARO, BREZTRI, FARXIGA, NURTEC ODT, Ozempic, NEFFY, KISUNLA.
Industry payments across IL — which companies pay providers there.
